Europe must move on from ‘simplistic’ pricing

June 22, 2010
Research and Development Europe, hta, pricing, pricing & Reimbursement

GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …

Pfizer withdraws blood cancer drug in US

June 22, 2010
Sales and Marketing AML, Mylotarg, Pfizer, blood cancer

The US regulatory body has withdrawn Pfizer’s leukaemia drug Mylotarg after it was linked to a number of deaths, and …

NHS targets and management costs in the firing line

June 22, 2010
NHS, NHS funding, NHS targets

Management costs and the use of targets are at the top of the government’s NHS hitlist, the health secretary Andrew Lansley has …

FDA tightens pharma’s responsibility for outsourcing

June 22, 2010
Manufacturing and Production FDA, GMP, manufacturing, outsourcing

Pharmaceutical manufacturers will be held more responsible for the activities of their suppliers and outsourcing partners under a new approach …

Manufacturing news in brief

June 22, 2010
Manufacturing and Production Almac, CPL Biologicals, KV Pharma, KV Pharmaceutical, NerPharMa, ProBioGen

German contract manufacturer ProBioGen is bought by Egypt’s Minapharm, plus there are facility updates from NerPharMa DS, CPL Biologicals and …

NDA_Panos

NDA appoints Dr Panos Tsintis

June 22, 2010
Sales and Marketing NDA, appointment, sales and marketing

European regulatory affairs consulting group NDA has appointed Dr Panos Tsintis medical advisor to NDA Regulatory Science in a move …

Dr Geoffrey Nichol joins Ikaria

June 22, 2010
Research and Development Ikaria, appointment, research and development

US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …

Working Life: Jo Ferdinando

June 22, 2010
Manufacturing and Production, Research and Development Shire, Working Life, careers

How did you find your way into your most current role? After completing a BSc in Microbiology and Virology at …

Andrew Witty

Let’s avoid further stand-offs, says Witty

June 22, 2010
Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing

Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …

Blog footer

Digital Pharma: Online trial safety reporting

June 21, 2010
Research and Development FDA, MHRA, digital research, drug safety

From September all serious adverse events that occur during clinical trials in the UK will have to be reported electronically …

GW laboratory

Bayer launches world’s first cannabis-derived prescription drug

June 21, 2010
Sales and Marketing Bayer, GW Pharmaceuticals, Sativex

Bayer Healthcare has launched the world’s first cannabis-derived prescription drug in the UK. Sativex treats the spasticity symptoms of multiple …

GSK tops access to medicines ranking

June 21, 2010
Sales and Marketing GlaxoSmithKline, developing world, medicines access

GlaxoSmithKline does the most of any pharma manufacturer to improve access to medicines needed in the developing world, according to …

Tasigna more effective than Glivec, says Novartis

June 21, 2010
Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia

Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …

Depomed pulls diabetes drug Glumetza

June 21, 2010
Manufacturing and Production Depomed, Glumetza, manufacturing compliance

Another pharmaceutical manufacturer has been forced to recall products because of contamination caused by a chemical used to treat wooden …

AMRI buys Hyaluron to enter prefilled syringes market

June 21, 2010
Manufacturing and Production AMRI, Hyaluron

Contract manufacturing organisation Albany Molecular Research Inc (AMRI) has added to its capabilities with the $27 million purchase of US …

Ecteinascidia turbinata

NICE rejects Yondelis in ovarian cancer

June 21, 2010
Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer

New cancer treatment Yondelis has been rejected by NICE in a preliminary ruling on its use in relapsed ovarian cancer. …

Avastin will remain gold standard for lung cancer to 2018

June 20, 2010
Decision Resources, NSCLC, Roche drug tipped to remain key to treatment, avastin

 Industry analysts Decision Resources believes that Roche’s Avastin plus chemotherapy agents will remain as the gold standard for the treatment …

NHS Football Fitness

Digital Pharma: Byte-sized roundup

June 18, 2010
Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media

This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …

Fishawack acquires Alpha-Plus

June 18, 2010
Medical Communications fishawack

Fishawack has acquired fellow medical communications agency Alpha-Plus as it continues its ‘buy and build’ expansion plan. This has recently …

Contract research news in brief

June 18, 2010
Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research

Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …

The Gateway to Local Adoption Series

Latest content